Here are three points:
1. The company’s total short interest was 2.24 million shares in June.
2. The firm’s stock has underperformed the S&P500 by 22.11 percent.
3. The company has a market cap of $600.03 million.
More articles on devices:
The efficacy of electrical bone stimulators & ultrasound for bone healing — Dr. Mohit Bhandari weighs in with new evidence
Global orthopedic trauma devices market to reach $9.4B by 2020: 4 things to know
Bristol Hospital 1st in Connecticut to offer Rotator Cuff Bioinductive Implant — 5 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
